DHR Stock: Unusual Options Flow Targets Danaher as Shares Trade Near 52-Week Lows
By TrendSpider Editor
Danaher Corporation is drawing attention in the options market today, with four unusual contracts flagging across both calls and puts totaling $1,716,009.80 in premium. DHR shares are trading at $190.75, up just 0.38% on the session, but the stock remains under pressure, sitting closer to its 52-wee
DHR Stock: Unusual Options Flow Targets Danaher as Shares Trade Near 52-Week Lows
Danaher Corporation is drawing attention in the options market today, with four unusual contracts flagging across both calls and puts totaling $1,716,009.80 in premium. DHR shares are trading at $190.75, up just 0.38% on the session, but the stock remains under pressure, sitting closer to its 52-week low of $171.00 than its 52-week high of $242.75. The options activity suggests traders are positioning for meaningful moves in multiple directions and across several timeframes.
Key Drivers of the DHR Stock Move
- Main Catalyst: Four unusual options contracts have been flagged in DHR today, spanning strikes from $115 to $210 and expiries ranging from April 2, 2026 through January 21, 2028. The dominant contract by size is a CALL at the $210 strike expiring May 15, 2026, with 4,562 contracts traded and open interest coverage of 93%. That single contract accounts for $1,459,840 of the total premium flow, making it the clear center of gravity in today's activity.
- Bull Case: The $210 CALL expiring May 15, 2026 represents a significant bullish bet that DHR can recover more than 10% from current levels within roughly seven weeks. At 4,562 contracts, this is the largest position flagged today and drives the overwhelming majority of total premium, signaling that at least one large participant sees meaningful upside from the current $190.75 price.
- Bear Case: Three of the four flagged contracts are puts. The most striking is a PUT at the $115 strike expiring January 21, 2028, which carries an open interest reading of 12,500%, the highest OI percentage of any contract flagged today. While it is deeply out of the money relative to the current price, the extreme OI ratio and long-dated nature suggest a trader is making a sizeable, deliberate hedge or directional bet on a severe downside scenario playing out over the next two years.
The forward setup for DHR is worth watching carefully. The stock has spent much of the past several months compressing in a range well below its 52-week high of $242.75, and today's mixed options flow reflects genuine uncertainty about the direction of the next major move. The near-term put at the $185 strike expiring April 2, 2026, just nine days away, carries an OI reading of 435%, suggesting elevated short-term concern around a level only about three points below the current price. Meanwhile, the longer-dated downside protection at $115 adds a tail-risk dimension to the picture that cannot be ignored. Investors should monitor whether the bullish call flow at $210 develops further momentum, or whether the put activity proves to be the more prescient signal as the company navigates its ongoing business transformation in the life sciences and diagnostics space.
DHR Unusual Options Activity
- Put: Strike $170 | Expiry April 24, 2026 | Volume 451 | Open Interest 293% | OTM
- Put: Strike $185 | Expiry April 2, 2026 | Volume 174 | Open Interest 435% | OTM
- Call: Strike $210 | Expiry May 15, 2026 | Volume 4,562 | Open Interest 93% | OTM
- Put: Strike $115 | Expiry January 21, 2028 | Volume 250 | Open Interest 12,500% | OTM
DHR Seasonality
Late March and early April have historically represented a transitional period for industrials and life sciences names as investors begin repositioning around first-quarter earnings season. With DHR's nearest options expiry landing on April 2, 2026, the short-dated put flow may reflect traders bracing for a catalyst or macro-driven volatility in the days ahead.
DHR Relative Performance
DHR's modest gain of 0.38% today offers little relief in the broader context of its 52-week range. Trading at $190.75 against a 52-week high of $242.75, the stock remains approximately 21% off its peak, underscoring the degree to which Danaher has lagged during periods when other large-cap industrials and healthcare technology names have shown more resilience. Until DHR can reclaim higher ground and reduce that gap meaningfully, the technical backdrop remains a headwind for bulls.